BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16971023)

  • 21. Biologic principles of immunotherapy for malignant gliomas.
    Han SJ; Kaur G; Yang I; Lim M
    Neurosurg Clin N Am; 2010 Jan; 21(1):1-16. PubMed ID: 19944962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of nitric oxide in tumor growth].
    Zaporozhan VN; Gozhenko AI; Korneenko TV; Dubinina VG
    Usp Fiziol Nauk; 2004; 35(1):66-82. PubMed ID: 15027174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biochemical exploration of energetic metabolism and oxidative stress in low grade gliomas: central and peripheral tumor tissue analysis].
    Lamari F; La Schiazza R; Guillevin R; Hainque B; Foglietti MJ; Beaudeux JL; Bernard M
    Ann Biol Clin (Paris); 2008; 66(2):143-50. PubMed ID: 18390424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration.
    Dey N; Crosswell HE; De P; Parsons R; Peng Q; Su JD; Durden DL
    Cancer Res; 2008 Mar; 68(6):1862-71. PubMed ID: 18339867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitric oxide, ischaemia and brain inflammation.
    Murphy S; Gibson CL
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1133-7. PubMed ID: 17956295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The immunobiology of malignant gliomas.
    Nano R; Ceroni M
    Funct Neurol; 2005; 20(1):39-42. PubMed ID: 15948568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Independent activation of Akt and NF-kappaB pathways and their role in resistance to TNF-alpha mediated cytotoxicity in gliomas.
    Sudheerkumar P; Shiras A; Das G; Jagtap JC; Prasad V; Shastry P
    Mol Carcinog; 2008 Feb; 47(2):126-36. PubMed ID: 17849421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma.
    Alexander A; Murtha A; Abdulkarim B; Mehta V; Wheatley M; Murray B; Riauka T; Hanson J; Fulton D; McEwan A; Roa W
    Clin Invest Med; 2006 Oct; 29(5):301-11. PubMed ID: 17144440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging therapies for malignant glioma.
    Lukas RV; Boire A; Nicholas MK
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S29-36. PubMed ID: 18076315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.
    Bruna A; Darken RS; Rojo F; Ocaña A; Peñuelas S; Arias A; Paris R; Tortosa A; Mora J; Baselga J; Seoane J
    Cancer Cell; 2007 Feb; 11(2):147-60. PubMed ID: 17292826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting epidermal growth factor receptor variant III: a novel strategy for the therapy of malignant glioma.
    Sonabend AM; Dana K; Lesniak MS
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S45-50. PubMed ID: 18076318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Correlated changes and value of redox-status, nitric oxide and blood supply in experimental malignant tumor growth].
    Kipiani V; Bejitashvili N; Gambashidze K; Sanikidze T
    Georgian Med News; 2007 Nov; (152):48-51. PubMed ID: 18175835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of nitric oxide in the brain during lipopolysaccharide-evoked systemic inflammation.
    Czapski GA; Cakala M; Chalimoniuk M; Gajkowska B; Strosznajder JB
    J Neurosci Res; 2007 Jun; 85(8):1694-703. PubMed ID: 17465018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas.
    Stojic J; Hagemann C; Haas S; Herbold C; Kühnel S; Gerngras S; Roggendorf W; Roosen K; Vince GH
    Neurosci Res; 2008 Jan; 60(1):40-9. PubMed ID: 17980449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feed-forward excitation of striatal neuron activity by frontal cortical activation of nitric oxide signaling in vivo.
    Ondracek JM; Dec A; Hoque KE; Lim SA; Rasouli G; Indorkar RP; Linardakis J; Klika B; Mukherji SJ; Burnazi M; Threlfell S; Sammut S; West AR
    Eur J Neurosci; 2008 Apr; 27(7):1739-54. PubMed ID: 18371082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.
    Pollack IF; Hamilton RL; James CD; Finkelstein SD; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL;
    J Neurosurg; 2006 Nov; 105(5 Suppl):418-24. PubMed ID: 17328268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Alternative pathways of nitric oxide formation in lactobacilli: EPR evidence for nitric oxide synthase activity].
    Iarullina DR; Il'inskaia ON; Aganov AV; Silkin NI; Zverev DG
    Mikrobiologiia; 2006; 75(6):731-6. PubMed ID: 17205795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric oxide and glioma: a target for novel therapy?
    Shinoda J; Whittle IR
    Br J Neurosurg; 2001 Jun; 15(3):213-20. PubMed ID: 11478055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The progression of gliomas is associated with cancer stem cell phenotype.
    Kong DS; Kim MH; Park WY; Suh YL; Lee JI; Park K; Kim JH; Nam DH
    Oncol Rep; 2008 Mar; 19(3):639-43. PubMed ID: 18288395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
    Wong ML; Prawira A; Kaye AH; Hovens CM
    J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.